Neuroscience Demand Diagnostic Biochips focuses on high-channel-count, miniaturized neural probes and electrophysiology data analysis software, signaling strong demand from academic and government research institutions pursuing advanced brain research and disease cures.

Global Expansion Recent European representation via Green Leaf Scientific and a global customer base indicate opportunity to expand regional sales through distributors, integrators, and local support for probes and software.

Strategic Partnerships Collaborations such as the ACRO Certify Aneuro in vivo electrophysiology solutions partnership suggest avenues to co-sell or bundle diagnostics hardware with complementary platforms, expanding addressable market.

Mid-market Focus With 11-50 employees and $1M–$10M in revenue, the company sits in the mid-market; target university labs, contract research organizations, and regional biotech players needing scalable neural recording solutions.

Emerging Growth Recent leadership additions and ongoing product capability shifts imply a growth trajectory; sales opportunities exist in upselling higher-channel-count probes, software analytics, and maintenance services as adoption widens.